Elizabeth (Liz) McKee Anderson Acquires 446 Shares of GSK plc (LON:GSK) Stock

GSK plc (LON:GSK) insider Elizabeth (Liz) McKee Anderson bought 446 shares of the company’s stock in a transaction on Monday, September 23rd. The shares were bought at an average cost of GBX 2,051 ($27.46) per share, for a total transaction of £9,147.46 ($12,248.88).

GSK Stock Down 0.2 %

Shares of GSK stock opened at GBX 1,527 ($20.45) on Thursday. GSK plc has a twelve month low of GBX 1,371.40 ($18.36) and a twelve month high of GBX 1,823.50 ($24.42). The stock has a market cap of £62.30 billion, a P/E ratio of 1,351.33, a P/E/G ratio of 1.34 and a beta of 0.31. The stock has a 50 day moving average of GBX 1,583.71 and a 200 day moving average of GBX 1,629.81. The company has a current ratio of 0.82, a quick ratio of 0.73 and a debt-to-equity ratio of 123.04.

GSK Dividend Announcement

The company also recently announced a dividend, which will be paid on Thursday, October 10th. Investors of record on Thursday, August 15th will be paid a GBX 15 ($0.20) dividend. This represents a dividend yield of 0.97%. The ex-dividend date of this dividend is Thursday, August 15th. GSK’s dividend payout ratio is currently 5,309.73%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on GSK shares. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,100 ($28.12) price objective on shares of GSK in a report on Thursday, June 27th. Citigroup cut their price objective on GSK from GBX 2,120 ($28.39) to GBX 1,900 ($25.44) and set a “buy” rating on the stock in a report on Friday, July 5th. JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of GSK in a report on Monday, July 29th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 1,850 ($24.77) price target on shares of GSK in a report on Tuesday, September 3rd. Finally, Shore Capital restated a “buy” rating on shares of GSK in a research note on Wednesday, August 28th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,842.50 ($24.67).

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.